LONDON (Reuters) - Makers of inhalers to treat asthma and chronic lung disease are racing to develop a new generation of smart devices with sensors to monitor if patients are using their puffers ...
A new study suggests that many patients aren’t waiting between puffs on their inhalers and may not be deriving the full benefits of the drugs. By Perri Klass, M.D. Asthma is the most common chronic ...
What type of asthma inhaler is right for you? In the U.S., 25 million people are affected by asthma. That’s roughly 1 in 13 adults and children. Asthma can be mild or severe. Some people with asthma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results